Launches Of New Intravenous Solution Injections For The Treatment Of Various Diseases Such As Dehydration, Gastrointestinal Diseases Is Expected To Drive The Intravenous Solution Market Growth

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, nonpyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others.

"Limited Time Offer"
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/1134

Market Dynamics

Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, according to the World Health Organization (WHO), in May 2017, there were around 1.7 billion annual cases of childhood diarrheal disease across the globe.

Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016.

Increasing cost of vitamin C intravenous therapy is expected to hinder the global intravenous solution market growth. For instance, in 2017, the China government took regulatory action of lowering vitamin C production owing to environmental concerns. This led to increase in prices of vitamin C by around 300% over the year. Furthermore, China produces 95% of the world’s vitamin C, which is used in food products, dietary supplements, and pharmaceuticals. The price of vitamin C was US$ 3.50 per kg in October 2016, which increased to US$ 12 per kg by September 2017, owing to environmental issues, which decreased China’s 30% of the vitamin C production.

Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1134

Major Key Players Are: Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited

Table of Content

Global Intravenous Solutions Market Research Report

Section 1: Global Intravenous Solutions Industry Overview
Section 2: Global Economic Impact on Intravenous Solutions Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Intravenous Solutions Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Intravenous Solutions Market Forecast

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1134

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.